417320000: Product containing naphazoline and pheniramine (medicinal product)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Product containing naphazoline (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)
\Medicinal product categorized by disposition (product)\Product containing histamine receptor antagonist (product)\Product containing histamine H1 receptor antagonist (product)\Product containing pheniramine (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)
\Medicinal product categorized by disposition (product)\Product containing histamine receptor antagonist (product)\Product containing propylamine derivative and histamine receptor antagonist (product)\Product containing pheniramine (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)

\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\...

\Product containing propylamine (product)\Product containing propylamine derivative and histamine receptor antagonist (product)\Product containing pheniramine (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)

\Product containing azole (product)\Product containing imidazole (product)\Product containing naphazoline (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)

\Product containing autonomic agent (product)\Product containing sympathomimetic (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Product containing naphazoline (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2009. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2546007010 Pheniramine + naphazoline (product) en Fully specified name Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
2548274017 Pheniramine + naphazoline en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3524416013 Product containing naphazoline and pheniramine (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3524417016 Naphazoline and pheniramine en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3524418014 Product containing naphazoline and pheniramine en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3667825017 Naphazoline and pheniramine product en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3715870014 Naphazoline- and pheniramine-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3638861000005111 pheniramin + naphazolin da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing naphazoline and pheniramine (medicinal product)	Is a	Product containing pheniramine (medicinal product)	true	Inferred relationship	Some
Product containing naphazoline and pheniramine (medicinal product)	Is a	Product containing naphazoline (medicinal product)	true	Inferred relationship	Some
Product containing naphazoline and pheniramine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Naphazoline (substance)	true	Inferred relationship	Some	1
Product containing naphazoline and pheniramine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Pheniramine (substance)	true	Inferred relationship	Some	2
Product containing naphazoline and pheniramine (medicinal product)	Is a	Product containing naphazoline in ophthalmic dosage form	false	Inferred relationship	Some
Product containing naphazoline and pheniramine (medicinal product)	Has manufactured dose form	Ocular dose form (dose form)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
pheniramin 0,0315 % + naphazolin 0,02675 % opløsning til oftalmisk anvendelse	Is a	False	Product containing naphazoline and pheniramine (medicinal product)	Inferred relationship	Some
naphazolinhydrochlorid + pheniramin	Is a	False	Product containing naphazoline and pheniramine (medicinal product)	Inferred relationship	Some
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Is a	False	Product containing naphazoline and pheniramine (medicinal product)	Inferred relationship	Some
Product containing only naphazoline and pheniramine (medicinal product)	Is a	True	Product containing naphazoline and pheniramine (medicinal product)	Inferred relationship	Some
Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)	Is a	True	Product containing naphazoline and pheniramine (medicinal product)	Inferred relationship	Some

This concept is not in any reference sets